Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 11, 2008
Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial
S Köpke, J Kasper, I Mühlhauser, et al.
Acta Neurologica Scandinavica
|
November 5, 2011
Treatment of steroid-unresponsive optic neuritis with plasma exchange
S Roesner, R Appel, J Gbadamosi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 17, 2005
Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study
J Liepert, D Mingers, C Heesen, et al.
Journal of the Neurological Sciences
|
May 29, 2013
Patient autonomy in multiple sclerosis--possible goals and assessment strategies
C Heesen, S Köpke, A Solari, et al.
European Journal of Neurology
|
August 24, 1999
Interleukin-12 is detectable in sera of patients with multiple sclerosis - association with chronic progressive disease course?
C Heesen, F Sieverding, B G Schoser, et al.
Acta Neurologica Scandinavica
|
April 26, 2003
Delivering the diagnosis of MS--results of a survey among patients and neurologists
C Heesen, J Kolbeck, S M Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 13, 2011
HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis
F Möller, J Poettgen, F Broemel, et al.
Neurology
|
March 18, 2009
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report
F Leypoldt, A Münchau, F Moeller, et al.
Psychoneuroendocrinology
|
July 3, 2007
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review
C Heesen, S M Gold, I Huitinga, et al.
Arthritis and Rheumatism
|
September 1, 1992
Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity
W H Schmitt, C Heesen, E Csernok, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 11, 2008
Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial
S Köpke, J Kasper, I Mühlhauser, et al.
Acta Neurologica Scandinavica
|
November 5, 2011
Treatment of steroid-unresponsive optic neuritis with plasma exchange
S Roesner, R Appel, J Gbadamosi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 17, 2005
Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study
J Liepert, D Mingers, C Heesen, et al.
Journal of the Neurological Sciences
|
May 29, 2013
Patient autonomy in multiple sclerosis--possible goals and assessment strategies
C Heesen, S Köpke, A Solari, et al.
European Journal of Neurology
|
August 24, 1999
Interleukin-12 is detectable in sera of patients with multiple sclerosis - association with chronic progressive disease course?
C Heesen, F Sieverding, B G Schoser, et al.
Acta Neurologica Scandinavica
|
April 26, 2003
Delivering the diagnosis of MS--results of a survey among patients and neurologists
C Heesen, J Kolbeck, S M Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 13, 2011
HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis
F Möller, J Poettgen, F Broemel, et al.
Neurology
|
March 18, 2009
Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report
F Leypoldt, A Münchau, F Moeller, et al.
Psychoneuroendocrinology
|
July 3, 2007
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review
C Heesen, S M Gold, I Huitinga, et al.
Arthritis and Rheumatism
|
September 1, 1992
Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity
W H Schmitt, C Heesen, E Csernok, et al.
Page
of 8